Data Foundry

Drug recalls 2025

Chlorpromazine Hydrochloride Tablets — Class II drug recall D-0632-2025

Ongoing recall by Zydus Pharmaceuticals (USA) Inc, reported 2025-09-17, distributed nationwide. CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Recall numberD-0632-2025
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmZydus Pharmaceuticals (USA) Inc, Pennington, NJ, United States
Recall initiated2025-09-03
Classified2025-09-10
Reported by FDA2025-09-17
DistributedNationwide (US)
Reason classescgmp
NDC70710-1129, 70710-1129-01, 70710-1129-02, 70710-1129-04, 70710-1130, 70710-1130-01, 70710-1130-02, 70710-1130-04, 70710-1131, 70710-1131-01, 70710-1131-02, 70710-1131-04, 70710-1132, 70710-1132-01, 70710-1132-02, 70710-1132-04, 70710-1133, 70710-1133-01, 70710-1133-02, 70710-1133-04
Lot numbersZ305060, Z305061, Z306323, Z401153, Z403015, Z403016, Z405591

Product

Chlorpromazine Hydrochloride Tablets, USP, 25 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1130-1

Reason for recall

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0632-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.